Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Plos One
|
November 19, 2013
Proteomic analysis of tissue from α1,3-galactosyltransferase knockout mice reveals that a wide variety of proteins and protein fragments change expression level
Louise Thorlacius-Ussing, Maja Ludvigsen, Svend Kirkeby, et al.
Emerging Infectious Diseases
|
April 20, 2019
Age-Dependent Increase in Incidence of Staphylococcus aureus Bacteremia, Denmark, 2008-2015
Louise Thorlacius-Ussing, Haakon Sandholdt, Anders Rhod Larsen, et al.
Microbiology Spectrum
|
April 19, 2022
Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia
Robert Strengen Bigseth, Håkon Sandholdt, Andreas Petersen, et al.
Current Issues in Molecular Biology
|
September 25, 2021
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
Maja Ludvigsen, Louise Thorlacius-Ussing, Henrik Vorum, et al.
International Journal of Molecular Sciences
|
May 20, 2020
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer
Maja Ludvigsen, Louise Thorlacius-Ussing, Henrik Vorum, et al.
Trials
|
May 4, 2019
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
Louise Thorlacius-Ussing, Christian Østergaard Andersen, Niels Frimodt-Møller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 7, 2021
Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled Cohort Study
Louise Thorlacius-Ussing, Håkon Sandholdt, Jette Nissen, et al.
BMJ Open
|
July 21, 2023
Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
Simone Bastrup Israelsen, Sandra Tingsgård, Louise Thorlacius-Ussing, et al.
Ugeskrift for Laeger
|
September 10, 2019
[Management of Staphylococcus aureus bacteraemia]
Louise Thorlacius-Ussing, Nis Pedersen Jørgensen, Jesper Smit, et al.
BMJ Open
|
May 8, 2023
Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial
Sandra Tingsgård, Simone Bastrup Israelsen, Louise Thorlacius-Ussing, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Plos One
|
November 19, 2013
Proteomic analysis of tissue from α1,3-galactosyltransferase knockout mice reveals that a wide variety of proteins and protein fragments change expression level
Louise Thorlacius-Ussing, Maja Ludvigsen, Svend Kirkeby, et al.
Emerging Infectious Diseases
|
April 20, 2019
Age-Dependent Increase in Incidence of Staphylococcus aureus Bacteremia, Denmark, 2008-2015
Louise Thorlacius-Ussing, Haakon Sandholdt, Anders Rhod Larsen, et al.
Microbiology Spectrum
|
April 19, 2022
Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia
Robert Strengen Bigseth, Håkon Sandholdt, Andreas Petersen, et al.
Current Issues in Molecular Biology
|
September 25, 2021
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
Maja Ludvigsen, Louise Thorlacius-Ussing, Henrik Vorum, et al.
International Journal of Molecular Sciences
|
May 20, 2020
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer
Maja Ludvigsen, Louise Thorlacius-Ussing, Henrik Vorum, et al.
Trials
|
May 4, 2019
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
Louise Thorlacius-Ussing, Christian Østergaard Andersen, Niels Frimodt-Møller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 7, 2021
Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled Cohort Study
Louise Thorlacius-Ussing, Håkon Sandholdt, Jette Nissen, et al.
BMJ Open
|
July 21, 2023
Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
Simone Bastrup Israelsen, Sandra Tingsgård, Louise Thorlacius-Ussing, et al.
Ugeskrift for Laeger
|
September 10, 2019
[Management of Staphylococcus aureus bacteraemia]
Louise Thorlacius-Ussing, Nis Pedersen Jørgensen, Jesper Smit, et al.
BMJ Open
|
May 8, 2023
Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial
Sandra Tingsgård, Simone Bastrup Israelsen, Louise Thorlacius-Ussing, et al.
Page
of 2